Noncompetitive Inhibition of MtFBA by 8-Hydroxyquinoline-2- Carboxylic Acid and Derivatives for Tuberculosis Therapeutics

The use of 8-hydroxyquinoline-2-carboxylic acid as an inhibitor against M. tuberculosis class II 1,6-biphosphate aldolase (MtFBA) was found to be a novel and effective alternative to existing antibiotic options. Previous class II FBA inhibitors either lacked specificity or druglike properties to be considered for further drug development. The MtFBA inhibitory and chemical attributes of 8-hydroxyquinoline-2-carboxylic acid and potential derivatives overcome both of these challenges. CeCe Ging 303-871-4230

Related Blog

Smart, interactive desk

Get ready to take your space management game to the next level with the University of Glasgow’s innovative project! By combining the

Mechanical Hamstring™

University of Delaware Technology Overview This device was created to allow athletes who suffer a hamstring strain to return to the field

Join Our Newsletter

                                                   Receive Innovation Updates, New Listing Highlights And More